Cargando…
Point and interval estimation in two-stage adaptive designs with time to event data and biomarker-driven subpopulation selection
In personalized medicine, it is often desired to determine if all patients or only a subset of them benefit from a treatment. We consider estimation in two-stage adaptive designs that in stage 1 recruit patients from the full population. In stage 2, patient recruitment is restricted to the part of t...
Autores principales: | Kimani, Peter K., Todd, Susan, Renfro, Lindsay A., Glimm, Ekkehard, Khan, Josephine N., Kairalla, John A., Stallard, Nigel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785132/ https://www.ncbi.nlm.nih.gov/pubmed/32363603 http://dx.doi.org/10.1002/sim.8557 |
Ejemplares similares
-
Point estimation following two‐stage adaptive threshold enrichment clinical trials
por: Kimani, Peter K., et al.
Publicado: (2018) -
Estimation bias in survival data within clinical trials that use adaptive seamless designs
por: Khan, Josephine, et al.
Publicado: (2015) -
Estimation after subpopulation selection in adaptive seamless trials
por: Kimani, Peter K., et al.
Publicado: (2015) -
Adjusting for treatment selection in phase II/III clinical trials with time to event data
por: Khan, Josephine N., et al.
Publicado: (2022) -
Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility
por: Kimani, Peter K, et al.
Publicado: (2013)